Skip to main content
OpenTrials
Completed

NCT Number: NCT02558998

Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care

The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-Small Cell Lung Carcinoma (NSCLC) Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All participants must be 18 years of age or older.
  • Patient participants must have Stage III, IV and/or recurrent NSCLC.
  • Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change
  • Patients must have working email address and internet access

Exclusion criteria

  • Any participant who cannot understand written or spoken English.
  • Any participant who is not competent to provide informed consent for study participation per the investigator.
  • Any participant who cannot be present for the related study visits and/or complete the post-test assessment

Treatment and study plan

Survey

Other

Primary outcomes

  1. Number of patient who completed surveys

    Time frame: 8 months

Sponsors and collaborators

Lead sponsor

Abramson Cancer Center at Penn Medicine

Other

Registry information

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Sep 24, 2015
Registry last updated
Feb 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.